Apr 16, 2018 18:10 pm UTC| Business
BERKELEY, Calif., April 16, 2018 -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced data from its ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist, in combination with...
RiskIQ to Deliver Threat Hunting Educational Workshops at RSA 2018
Apr 16, 2018 18:06 pm UTC| Business
SAN FRANCISCO, RSA 2018, April 16, 2018 -- RiskIQ, the leader in digital threat management, today announced the company will present a series of educational threat hunting workshops during RSA 2018 taking place the week...
Metro Detroit Employers. Now Hiring with 500 Job Openings
Apr 16, 2018 18:06 pm UTC| Business
DETROIT, April 16, 2018 -- JobFairGiant.com is sponsoring the Metro Detroit Career Expo. The “Career Expo” will take place on Thursday, April 26, 2018 from 9 a.m. to 3 p.m. at the Edward Hotel Dearborn. ...
AgreeYa Solutions to Exhibit Advanced Software, Solutions and Services at CCISDA Spring Conference
Apr 16, 2018 18:04 pm UTC| Business
FOLSOM, Calif., April 16, 2018 -- AgreeYa Solutions—a leading global software, solutions and services company—is proudly exhibiting at the California County Information Services Directors Association (CCISDA) Conference...
Sierra Monitor Corporation Declares Quarterly Cash Dividend of $0.01 per Share
Apr 16, 2018 18:01 pm UTC| Business
Twenty-third consecutive quarterly dividend issued by company Milpitas, California, April 16, 2018 -- Sierra Monitor Corporation (OTCQB: SRMC), a provider of Industrial Internet of Things (IIoT) solutions that target...
Newport Beach Going “John Wayne Crazy” With Celebration Cruises starting April 25th
Apr 16, 2018 18:01 pm UTC| Business
Newport Beach, April 16, 2018 -- Newport Beach, California (April 15, 2018) – Hornblower Cruises Events continues its tradition with an exclusive series of cruises honoring John Wayne which begin on April 25th 2018 on...
Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy
Apr 16, 2018 18:01 pm UTC| Business
Heidelberg, Germany, April 16, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today presented a poster entitled...